Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
La Roche-Posay is a leading French dermocosmetic brand owned by L'Oréal, specializing in skincare solutions for sensitive and compromised skin. The company's formulations are centered on the unique properties of La Roche-Posay Thermal Spring Water, which is rich in selenium and known for its soothing and antioxidant benefits. Collaborating with over 90,000 dermatologists worldwide, the brand develops products for conditions such as acne, eczema, rosacea, and sun-induced damage. Key product lines include Anthelios for UV protection, Effaclar for oily and acne-prone skin, and Lipikar for lipid-depleted skin. La Roche-Posay is a pioneer in skin microbiome research, integrating prebiotic ingredients into its formulations to support skin barrier health. The brand's products are widely recommended by healthcare professionals and are available in pharmacies and clinical settings globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on La Roche-Posay.